Enanta Pharmaceuticals (ENTA) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to -$188.9 million.
- Enanta Pharmaceuticals' Enterprise Value rose 2390.22% to -$188.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$188.9 million, marking a year-over-year increase of 2390.22%. This contributed to the annual value of -$188.9 million for FY2025, which is 2390.22% up from last year.
- Per Enanta Pharmaceuticals' latest filing, its Enterprise Value stood at -$188.9 million for Q3 2025, which was up 2390.22% from -$204.1 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Enterprise Value registered a high of -$188.9 million during Q3 2025, and its lowest value of -$386.6 million during Q2 2023.
- Moreover, its 5-year median value for Enterprise Value was -$249.2 million (2022), whereas its average is -$264.1 million.
- As far as peak fluctuations go, Enanta Pharmaceuticals' Enterprise Value tumbled by 5720.19% in 2023, and later soared by 4048.27% in 2024.
- Quarter analysis of 5 years shows Enanta Pharmaceuticals' Enterprise Value stood at -$259.1 million in 2021, then increased by 17.21% to -$214.5 million in 2022, then crashed by 57.2% to -$337.2 million in 2023, then surged by 35.73% to -$216.7 million in 2024, then increased by 12.84% to -$188.9 million in 2025.
- Its Enterprise Value stands at -$188.9 million for Q3 2025, versus -$204.1 million for Q2 2025 and -$193.4 million for Q1 2025.